ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHARLES RAINE M.D.

Endocrinology, Diabetes Metabolism

15,625

$707K

453
354 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 48%

$45
Average prescription price

Avg: $128

RAY VAUGHTERS MD

Endocrinology, Diabetes Metabolism

9,420

$983K

888
605 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 48%

$104
Average prescription price

Avg: $128

SAMUEL YEBOAH M.D.

Endocrinology, Diabetes Metabolism

8,257

$1.12M

775
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$136
Average prescription price

Avg: $128

DONALD EAGERTON M.D.

Endocrinology, Diabetes Metabolism

5,886

$955K

405
303 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 48%

$162
Average prescription price

Avg: $128

ROBERT WOZNIAK M.D.

Endocrinology, Diabetes Metabolism

5,172

$807K

551
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 48%

$156
Average prescription price

Avg: $128

MAYTE SANDRIN M.D.

Endocrinology, Diabetes Metabolism

4,833

$759K

357
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 48%

$157
Average prescription price

Avg: $128

USAH LILAVIVAT MD

Endocrinology, Diabetes Metabolism

4,358

$408K

257
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 48%

$94
Average prescription price

Avg: $128

SANDRA WEBER M.D.

Endocrinology, Diabetes Metabolism

3,678

$573K

239
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$156
Average prescription price

Avg: $128

JAVAID WANI MD

Endocrinology, Diabetes Metabolism

3,581

$507K

286
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 48%

$142
Average prescription price

Avg: $128

MARY KEMICK M.D.

Endocrinology, Diabetes Metabolism

3,457

$607K

323
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 48%

$176
Average prescription price

Avg: $128

JOHN BRUCH M.D.

Endocrinology, Diabetes Metabolism

3,379

$318K

268
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$94
Average prescription price

Avg: $128

FRANK FERRARO M.D.

Endocrinology, Diabetes Metabolism

3,065

$473K

275
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 48%

$154
Average prescription price

Avg: $128

JOHN CULLETON MD

Endocrinology, Diabetes Metabolism

3,002

$656K

344
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 48%

$219
Average prescription price

Avg: $128

MOJGAN RAHMANI MD

Endocrinology, Diabetes Metabolism

2,898

$418K

325
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

70%
prescriptions for brand name drugs

Avg: 48%

$144
Average prescription price

Avg: $128

ALAN HUELLMANTEL M.D.

Endocrinology, Diabetes Metabolism

2,890

$98.9K

266
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 48%

$34
Average prescription price

Avg: $128

PAIGE GAULT MD

Endocrinology, Diabetes Metabolism

2,883

$509K

309
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 48%

$177
Average prescription price

Avg: $128

GERALD MIELE MD

Endocrinology, Diabetes Metabolism

2,697

$451K

174
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

80%
prescriptions for brand name drugs

Avg: 48%

$167
Average prescription price

Avg: $128

PAUL BUNN MD

Endocrinology, Diabetes Metabolism

2,665

$418K

331
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 48%

$157
Average prescription price

Avg: $128

EVERETTE WALTON MD

Endocrinology, Diabetes Metabolism

2,520

$239K

204
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 48%

$95
Average prescription price

Avg: $128

KIMBERLY PUGH M.D.

Endocrinology, Diabetes Metabolism

2,461

$327K

227
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 48%

$133
Average prescription price

Avg: $128

BEATRICE HULL M.D.

Endocrinology, Diabetes Metabolism

2,434

$365K

252
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 48%

$150
Average prescription price

Avg: $128

MEENAKSHI PANDE MD

Endocrinology, Diabetes Metabolism

2,306

$316K

269
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 48%

$137
Average prescription price

Avg: $128

ORLIN SERGEV M.D., PH.D.

Endocrinology, Diabetes Metabolism

2,094

$296K

246
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 48%

$141
Average prescription price

Avg: $128

TIMOTHY GRAY MD

Endocrinology, Diabetes Metabolism

2,077

$190K

205
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 48%

$92
Average prescription price

Avg: $128

LOUIS HAENEL DO

Endocrinology, Diabetes Metabolism

2,075

$427K

453
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$206
Average prescription price

Avg: $128

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank